The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
Predictors and rates of adverse events (AEs) among non-metastatic prostate cancer (nmPC) patients (pts) treated with bicalutamide, abiraterone, or enzalutamide following surgical/medical castration.
 
Anuj Shah
Research Funding - Bayer (Inst)
 
Arif Hussain
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Novartis
Research Funding - Agensys; Bayer; Cerulean Pharma; Clovis Oncology; Merck; Sotio
 
Ruchit Shah
Research Funding - Bayer (Inst); Merck (Inst); Pfizer (Inst)
 
Shelly Ikeme
Employment - Bayer; TissueTech
Leadership - Bayer; TissueTech
Stock and Other Ownership Interests - TissueTech
Research Funding - Bayer; Thomas Jefferson University; TissueTech
Travel, Accommodations, Expenses - Bayer; TissueTech
Other Relationship - Bayer
 
Ateesha F. Mohamed
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Marc Botteman
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Kite/Gilead (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Helsinn Therapeutics (Inst); Kite/Gilead (Inst)
Other Relationship - Pharmerit
 
Reg Waldeck
No Relationships to Disclose